During the past years, there has been a global outbreak of allergic diseases, presenting a
considerable medical and socioeconomical burden. A large fraction of allergic diseases is …

Recent research into the pathophysiology and treatment of atopic dermatitis (AD) has shown
notable progress. An increasing number of aspects of the immune system are being …

The “epithelial barrier hypothesis” proposes that the exposure to various epithelial barrier–
damaging agents linked to industrialization and urbanization underlies the increase in …

The prevalence and severity of dermatological conditions such as atopic dermatitis have
increased dramatically during recent decades. Many of the factors associated with an …

Background Atopic dermatitis (AD) is a heterogeneous, chronic inflammatory skin disease
linked to skin microbiome dysbiosis with reduced bacterial diversity and elevated relative …

Background Dupilumab, an antibody against interleukin‐4 receptor α, has demonstrated
elegant efficacy and safety profiles in patients with moderate‐to‐severe atopic dermatitis …

The skin microbiota of atopic dermatitis (AD) patients is characterized by increased
Staphylococcus aureus colonization, which exacerbates disease symptoms and has been …

Atopic eczema (AE) is an inflammatory skin disease with involvement of genetic,
immunological and environmental factors. One hallmark of AE is a skin barrier disruption on …

Background Atopic dermatitis (AD) is a frequent and heterogeneous inflammatory skin
disease, for which personalized medicine remains a challenge. High‐throughput …

Several microbiome studies have recently demonstrated microbial dysbiosis in various
chronic inflammatory skin diseases, and it is considered an important role in the …